ICU Medical (ICUI)
(Delayed Data from NSDQ)
$108.19 USD
+0.53 (0.49%)
Updated Jun 5, 2024 04:00 PM ET
After-Market: $108.20 +0.01 (0.01%) 4:34 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
Brokerage Reports
ICU Medical, Inc. [ICUI]
Reports for Purchase
Showing records 261 - 280 ( 292 total )
Company: ICU Medical, Inc.
Industry: Medical - Products
Healthcare - 3Q 2012: Quarterly Medical Technology Trading & Acquisition Update
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: ICU Medical, Inc.
Industry: Medical - Products
ICUI: Mgmt. Check In: Good Execution in 1H:12, Confidence With Base Business, New Products Could be Impactful Latest Hospira Warning Letter Should Not Impact ICU Medical
Provider: COLLIERS SECURITIES
Analyst: HUSAIN J
Company: ICU Medical, Inc.
Industry: Medical - Products
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ICU Medical, Inc.
Industry: Medical - Products
Company: ICU Medical, Inc.
Industry: Medical - Products
Good Quarter; More Margin, Less Growth This Year; Buy on Any Weakness
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: ICU Medical, Inc.
Industry: Medical - Products
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ICU Medical, Inc.
Industry: Medical - Products
2Q12 Preview: Could See Higher EPS;Consistent 2012 Outlook
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: ICU Medical, Inc.
Industry: Medical - Products
Healthcare: Med Tech: The Vote Is In - ACA Upheld; Device Tax a Headwind into 2013
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: ICU Medical, Inc.
Industry: Medical - Products
Medical Technology: Thoughts on Our Medical Technology Universe Heading Into the Dog Days of Summer
Provider: COLLIERS SECURITIES
Company: ICU Medical, Inc.
Industry: Medical - Products
Med Tech Earnings Wrap-Up: What Looks Good Out of 1Q12
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: ICU Medical, Inc.
Industry: Medical - Products
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ICU Medical, Inc.
Industry: Medical - Products
Raising Target on Improved FY13 Earnings Outlook, Value; Maintain Buy
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: ICU Medical, Inc.
Industry: Medical - Products
ICUI: Good 1Q:12 Strong IV Therapy, Solid OUS Growth, and Pending New Products Keeps Us BUY Rated on ICU Medical
Provider: COLLIERS SECURITIES
Company: ICU Medical, Inc.
Industry: Medical - Products
Company: ICU Medical, Inc.
Industry: Medical - Products
Healthcare - 1Q 2012: Quarterly Medical Technology Trading & Acquisition Valuation Update
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: ICU Medical, Inc.
Industry: Medical - Products
C. K. COOPER HEALTHCARE DROPPING COVERAGE
Provider: C.K. Cooper and Company
Company: ICU Medical, Inc.
Industry: Medical - Products
ICUI: Checking In With ICU Medical at the Society of Critical Care Medicines 41st Annual Congress
Provider: COLLIERS SECURITIES
Company: ICU Medical, Inc.
Industry: Medical - Products
ICUI: 4Q11: Slightly Soft on Top, Beat on Bottom 2012 Guidance and Weak Critical Care Business Might Disappoint
Provider: COLLIERS SECURITIES
Company: ICU Medical, Inc.
Industry: Medical - Products
Medical Technology: We Believe Recent Pricing Pressures for Infusion Disposables Are Unique to CareFusion
Provider: COLLIERS SECURITIES
Company: ICU Medical, Inc.
Industry: Medical - Products
ICUI: Stable Growth for Must Need Medical Consumables Manufacturer Initiating Coverage of ICU Medical (ICUI) With a Buy Rating, PT $53
Provider: COLLIERS SECURITIES